Your browser doesn't support javascript.
loading
Cancer-associated histone mutation H2BG53D disrupts DNA-histone octamer interaction and promotes oncogenic phenotypes.
Wan, Yi Ching Esther; Leung, Tsz Chui Sophia; Ding, Dongbo; Sun, Xulun; Liu, Jiaxian; Zhu, Lina; Kang, Tze Zhen Evangeline; Yang, Du; Zhang, Yuchen; Zhang, Jitian; Qian, Chengmin; Huen, Michael Shing Yan; Li, Qing; Chow, Maggie Zi Ying; Zheng, Zongli; Han, Junhong; Goel, Ajay; Wang, Xin; Ishibashi, Toyotaka; Chan, Kui Ming.
Afiliação
  • Wan YCE; Department of Biomedical Sciences, City University of Hong Kong, Hong Kong, China.
  • Leung TCS; Key Laboratory of Biochip Technology, Biotech and Health Centre, Shenzhen Research Institute of City University of Hong Kong, Shenzhen, China.
  • Ding D; Division of Life Science, Hong Kong University of Science and Technology, Hong Kong, China.
  • Sun X; Division of Life Science, Hong Kong University of Science and Technology, Hong Kong, China.
  • Liu J; Division of Life Science, Hong Kong University of Science and Technology, Hong Kong, China.
  • Zhu L; Department of Biomedical Sciences, City University of Hong Kong, Hong Kong, China.
  • Kang TZE; Key Laboratory of Biochip Technology, Biotech and Health Centre, Shenzhen Research Institute of City University of Hong Kong, Shenzhen, China.
  • Yang D; Department of Biomedical Sciences, City University of Hong Kong, Hong Kong, China.
  • Zhang Y; Key Laboratory of Biochip Technology, Biotech and Health Centre, Shenzhen Research Institute of City University of Hong Kong, Shenzhen, China.
  • Zhang J; Department of Biomedical Sciences, City University of Hong Kong, Hong Kong, China.
  • Qian C; Key Laboratory of Biochip Technology, Biotech and Health Centre, Shenzhen Research Institute of City University of Hong Kong, Shenzhen, China.
  • Huen MSY; State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences and Peking-Tsinghua Center for Life Sciences, Peking University, Peking, China.
  • Li Q; Department of Biomedical Sciences, City University of Hong Kong, Hong Kong, China.
  • Chow MZY; Key Laboratory of Biochip Technology, Biotech and Health Centre, Shenzhen Research Institute of City University of Hong Kong, Shenzhen, China.
  • Zheng Z; Department of Biomedical Sciences, City University of Hong Kong, Hong Kong, China.
  • Han J; Key Laboratory of Biochip Technology, Biotech and Health Centre, Shenzhen Research Institute of City University of Hong Kong, Shenzhen, China.
  • Goel A; School of Biomedical Sciences, The University of Hong Kong, Hong Kong, China.
  • Wang X; School of Biomedical Sciences, The University of Hong Kong, Hong Kong, China.
  • Ishibashi T; State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences and Peking-Tsinghua Center for Life Sciences, Peking University, Peking, China.
  • Chan KM; Ming Wai Lau Centre for Reparative Medicine, Karolinska Institutet, Hong Kong, China.
Signal Transduct Target Ther ; 5(1): 27, 2020 03 06.
Article em En | MEDLINE | ID: mdl-32296031
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: DNA / Histonas / Proteínas de Ligação a DNA / Neoplasias Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Signal Transduct Target Ther Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: DNA / Histonas / Proteínas de Ligação a DNA / Neoplasias Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Signal Transduct Target Ther Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China